Pura Vida Investments, LLC Beam Therapeutics Inc. Transaction History

Pura Vida Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$53.73 - $82.16 $751,037 - $1.15 Million	-13,978 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$68.02 - $99.06 $720,671 - $1.05 Million	-10,595 Reduced 43.12%	13,978 $1.11 Million
Q3 2021 Nov 15, 2021	SELL	$84.37 - $133.6 $36,025 - $57,047	-427 Reduced 1.71%	24,573 $2.14 Million
Q2 2021 Aug 16, 2021	BUY	$64.12 - $128.71 $1.6 Million - $3.22 Million	25,000 New	25,000 $3.22 Million

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.69B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.